Pethidine Hydrochloride 50mg/ml Solution for Injection
*Company:
ADVANZ PharmaStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 08 November 2022
File name
Pethidine hydrochloride Solution for injection 50 mgml - PA 73141-IE_PIL.pdf
Reasons for updating
- Change to section 2 - use in children and adolescents
- Change to section 6 - date of revision
Updated on 08 November 2022
File name
Pethidine hydrochloride Solution for injection 50 mgml - PA 73141-IE_SPC.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 5.2 - Pharmacokinetic properties
- Change to section 10 - Date of revision of the text
- Updated inline with QRD template and/or excipient guideline
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 31 March 2022
File name
Pethidine Hydrochloride 50mgml Solution for Injection-IE-SPC.pdf
Reasons for updating
- Change due to harmonisation of SPC
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 31 March 2022
File name
Pethidine Hydrochloride 50mgml Solution for Injection-IE-PIL.pdf
Reasons for updating
- Change due to harmonisation of PIL
Updated on 31 December 2021
File name
Pethidine Hydrochloride 50mgml Solution for Injection_SPC_IE.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 31 December 2021
File name
Pethidine Hydrochloride 50mgml Solution for Injection_PIL_IE.pdf
Reasons for updating
- New PIL for new product
ADVANZ Pharma
Address:
Dashwood House, 69 Old Broad Street, London, EC2M 1QS, United KingdomMedical Information E-mail:
medicalinformation@advanzpharma.comTelephone:
+44 (0)208 588 9131Website:
https://www.advanzpharma.comMedical Information Direct Line:
+353 1800 851 119Customer Care direct line:
+353 1 5294 230